Sunil Healthcare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022
For the full year, sales was INR 1,191.64 million compared to INR 906.2 million a year ago. Revenue was INR 1,208.4 million compared to INR 961.99 million a year ago. Net income was INR 64.21 million compared to net loss of INR 6.38 million a year ago. Basic earnings per share from continuing operations was INR 6.26 compared to basic loss per share from continuing operations of INR 0.62 a year ago. Diluted earnings per share from continuing operations was INR 6.26 compared to diluted loss per share from continuing operations of INR 0.62 a year ago.